Help Families Pursue What Matters

Donate

You can help families grow together

Donate Now

The Sakita-Miwa classification (also known as the Sakita-Fukutomi classification) is a widely used endoscopic staging system for peptic ulcers, primarily gastric and duodenal ulcers. It categorizes the life cycle of an ulcer into three major stages—Active (A), Healing (H), and Scarring (S)—each subdivided into two sub-stages to provide a total of six steps in the healing process. 1. Active Stage (A)

This stage represents the initial, acute phase of the ulcer where the mucosal defect is most prominent.

A1 (Active-1): The ulcer is deep with a thick "white coating" (slough) at the base. The surrounding mucosa is edematously swollen, and no regenerating epithelium is visible.

A2 (Active-2): The surrounding edema decreases, and the ulcer margin becomes clear. A small amount of regenerating epithelium may begin to appear at the very edge of the margin. 2. Healing Stage (H)

In this stage, the body actively repairs the defect, and the ulcer begins to shrink.

H1 (Healing-1): The white coating becomes thinner, and regenerating epithelium extends into the ulcer base. The diameter of the defect typically reduces to about one-half to two-thirds of its original size in the A1 stage.

H2 (Healing-2): The defect is significantly smaller than in H1, and the regenerating epithelium covers most of the ulcer floor. The white coating is reduced to only about a quarter or one-third of its original area. 3. Scarring Stage (S)

This stage marks the completion of the healing process, where the mucosal defect is fully closed.

S1 (Scar-1 / Red Scar): The regenerating epithelium completely covers the ulcer floor, and the white coating has disappeared. The area appears markedly red due to the presence of many new capillaries.

S2 (Scar-2 / White Scar): Over time, the redness fades as the capillaries decrease, and the area becomes a pale, "white scar" that eventually blends with the surrounding normal mucosa. Summary Table Key Endoscopic Feature Active (A) A1 Thick slough, significant edema, no regeneration A2 Clearer margins, reduced edema, initial regeneration Healing (H) H1 Thin slough, defect reduced by ~50%, more regeneration H2 Minimal slough, defect mostly covered by new tissue Scarring (S) S1 Red scar; no slough; complete epithelial coverage S2 White scar; pale appearance; fully healed

This system is frequently used in clinical research, such as Randomized Clinical Trials, to evaluate the effectiveness of Proton Pump Inhibitors (PPIs) or other ulcer-healing medications.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

Sakita-Miwa Classification is a widely used endoscopic system for staging the healing process of peptic ulcers (gastric and duodenal). It categorizes ulcers into three main stages—Active, Healing, and Scarring—each with two sub-stages. 1. Active Stage (A)

The ulcer is in its most acute phase, characterized by a deep floor and a thick "white coating" or slough. Intestinal Research A1 (Active-1):

The ulcer base is covered with a thick white slough. The surrounding mucosa is intensely swollen (edematous) and red. No regenerative epithelium (new skin) is visible. A2 (Active-2):

The edema in the surrounding mucosa begins to decrease. The ulcer floor remains covered with slough, but the margins become more distinct. Intestinal Research 2. Healing Stage (H)

The body begins to repair the tissue, and the ulcer significantly reduces in size. Intestinal Research H1 (Healing-1):

A thin layer of regenerating epithelium (appearing as a reddish or pale area) begins to creep in from the edges of the ulcer. The slough on the ulcer floor begins to thin and contract. H2 (Healing-2):

The regenerating epithelium covers most of the ulcer floor, leaving only a small amount of white slough in the center. The ulcer is notably shallower. Intestinal Research 3. Scarring Stage (S)

The ulcer is considered clinically cured once it reaches this stage, as the white coating has completely disappeared. ScienceDirect.com S1 (Scar-1 / Red Scar):

The white slough is completely gone. The area is covered by new, red-colored regenerating epithelium. This is often referred to as a "red scar". S2 (Scar-2 / White Scar):

Over time, the redness fades. The area turns into a pale, flat, or slightly depressed "white scar". Clinical Scoring System

In research settings, these stages are often converted into numerical "healing scores" to track progress: ScienceDirect.com Healing Score (Standard) Description Acute active ulcer Resolving active ulcer Early healing Advanced healing Red scar (Cured) White scar (Cured) Note: Some studies use a reversed 6-point scale (A1=6, S2=1) depending on the specific trial protocol. PubMed Central (PMC) (.gov) used for bleeding ulcers?

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

The Sakita-Miwa classification is a standard endoscopic staging system used to evaluate the healing process of gastric and duodenal ulcers. It divides ulcer progression into three main stages (Active, Healing, and Scarring), with each further subdivided into two levels. Classification Stages The system uses the following six-stage categorical scale: Stage Description A1 Acute phase; thick white coating (slough) and sharp edges. A2

Slough becomes thinner; regenerative epithelium begins to appear. H1

Significant reduction in slough; clear signs of marginal regeneration. H2 Ulcer becomes very small; slough is nearly gone. S1 Scarring 1 Red scar; the white coating has completely disappeared. S2 Scarring 2

White scar; the lesion is completely healed and mucosal folds normalize. Relevant Papers

The classification was originally established in the early 1970s. While the original primary text is often cited as a textbook or early Japanese journal entry, you can find the classification detailed and applied in these authoritative research papers:

Original/Reference Source: Sakita T, et al. "Endoscopic diagnosis of ulcer—Classification of the ulcer stage." Japan Journal of Gastroenterology (1971).

Modern Application: The value of oral contrast-enhanced gastric ultrasonography (OCUS) in the staging of benign peptic ulcer (BPU) published in Nature Scientific Reports (2024).

Clinical Efficacy Study: Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients published in Digestive Diseases (2011).

Comparative Trial: Randomised clinical trial: tegoprazan or lansoprazole in the treatment of gastric ulcer in Alimentary Pharmacology & Therapeutics (2020).

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

However, "Sakitamiwa" is not a recognized term in mainstream taxonomy (biology), medical classification (ICD/DSM), video game lore, anime/manga, or known fictional universes.

It appears to be either:

  1. A misspelling of a known name/term
  2. A personal name (e.g., an OC or username)
  3. A term from a very niche or private work

To help you generate the content you need, here are the most likely classifications based on how the term sounds and is structured:

10. Implications and next steps

If you want, I can:

The Sakita-Miwa classification is a widely used system in gastroenterology for staging the progression and healing of gastric and duodenal ulcers. First described by Sakita and Miwa, this classification helps clinicians determine whether an ulcer is in an active, healing, or scarring phase based on its endoscopic appearance. The Six Stages of Sakita-Miwa Classification

The system categorizes ulcers into three main stages, each subdivided into two further phases. 1. Active Stage (Stage A) This represents the acute phase of the ulcer.

A1 (Active 1): The ulcer is deep with a thick white or yellow slough (exudate) at the base. The margins are sharp and often swollen, sometimes referred to as the "lip-like sign".

A2 (Active 2): The edema at the ulcer margin begins to subside, and the "lip-like sign" is less prominent. The ulcer base remains covered with slough. 2. Healing Stage (Stage H)

The ulcer begins to shrink and the body starts the repair process.

H1 (Healing 1): A regenerating epithelium begins to form at the edges, and the white coating at the base starts to thin and shrink.

H2 (Healing 2): The ulcer becomes significantly smaller and shallower. The regenerating epithelium covers more of the base, and the white coating is significantly reduced. 3. Scarring Stage (Stage S) The ulcer has essentially closed, leaving behind a scar.

S1 (Scar 1/Red Scar): The white coating has completely disappeared, and the area is covered by newly formed, reddish regenerating epithelium. This is often called a "red scar".

S2 (Scar 2/White Scar): Over several months, the redness fades, and the area becomes pale or white, matching the surrounding mucosa. This is known as a "white scar". Clinical Significance Clinicians use this classification to:

Monitor Healing: Track the progress of treatment (e.g., using Proton Pump Inhibitors) over time.

Standardize Communication: Provide a universal language for endoscopists to describe ulcer activity.

Research: Use as a primary or secondary endpoint in clinical trials for new gastroprotective drugs.

1. Phonetic / Linguistic Classification

3. Diagnostic Criteria Used in the System

The classification relies on a scoring system (often adapted from the Indonesian Pediatric Society scoring system) which includes:

  1. Contact History: Close contact with an adult with infectious TB.
  2. Clinical Symptoms: Cough > 2 weeks, fever, night sweats, weight loss/failure to thrive.
  3. Tuberculin Skin Test (TST/Mantoux): Positive induration.
  4. Radiological Findings: Chest X-ray abnormalities consistent with TB.
  5. Bacteriological Confirmation: Positive sputum or gastric aspirate (though often negative in children).

7. Case study (hypothetical, concise)

Group I: Primarily Pulmonary TB (Respiratory Focus)

This group includes children where the tuberculosis bacteria are primarily located in the lungs and thoracic cavity.

Diagnostic Approach (Practical Steps)

  1. History: Onset (present at birth vs evolving postnatally), growth pattern, symptoms (pain, bleeding, ulceration), family history.
  2. Exam: Color, compressibility, warmth, bruit, associated syndromic signs.
  3. First-line imaging: Duplex ultrasound to assess flow characteristics.
  4. Advanced imaging: MRI/MRA for extent and surgical planning.
  5. Pathology/genetics: Biopsy when diagnosis unclear; immunohistochemistry (GLUT1); targeted genetic testing for syndromic/overgrowth cases.

Conclusion

The Sakitamiwa classification groups congenital cutaneous and soft-tissue anomalies into four actionable categories—vascular malformations, vascular tumors, hamartomas/overgrowth syndromes, and developmental epidermal/dermal defects—emphasizing morphology, natural history, diagnostics, and tailored management to guide clinicians toward appropriate care.

If you meant a different "Sakitamiwa" topic (historical, taxonomic, or from another field), tell me which and I’ll rewrite the essay accordingly.

Related search suggestions provided.

The Sakita-Miwa classification is a widely used endoscopic staging system for assessing the healing process of gastric ulcers

. It categorizes the lifecycle of an ulcer into six distinct sub-stages across three major phases: ClinicalTrials.gov 1. Active Stage (A)

This stage represents the initial, most severe phase of the ulcer where the lesion is fully formed and active. PubMed Central (PMC) (.gov) A1 (Active 1):

The ulcer is deep, covered with a thick white or yellow coating (slough), and the surrounding tissue (gastric wall) is significantly swollen and reddened. A2 (Active 2):

The ulcer remains active, but the surrounding swelling begins to decrease, and the edges of the ulcer become more defined. ClinicalTrials.gov 2. Healing Stage (H)

In this phase, the ulcer begins to shrink as new tissue (epithelium) starts to regrow. giresearch.ph H1 (Healing 1):

The coating at the base of the ulcer becomes thinner, and new regenerative tissue begins to grow inward from the edges, making the ulcer smaller. H2 (Healing 2):

The ulcer is very shallow and nearly covered by new tissue. The surrounding inflammation has largely disappeared. PubMed Central (PMC) (.gov) 3. Scarring Stage (S)

This is the final stage where the ulcer has completely closed, leaving only a scar behind. ClinicalTrials.gov S1 (Scarring 1/Red Scar):

The ulcer has disappeared, replaced by a red scar consisting of young, delicate tissue. S2 (Scarring 2/White Scar):

Over time, the red scar matures and turns white, indicating the final stage of complete healing. 臨床研究等提出・公開システム Summary Table Clinical Appearance Deep ulcer, thick slough, heavy swelling Defined ulcer edges, reduced swelling Thin slough, regenerative tissue growth Shallow ulcer, nearly healed Red scar (new tissue) White scar (mature tissue)

This system is essential for doctors to determine if a treatment (like proton pump inhibitors ) is working and to predict the risk of gastrointestinal bleeding or recurrence. giresearch.ph Forrest classification , which is used to assess the risk of active from these ulcers?

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

Clinical Report: Sakita-Miwa Classification for Gastric Ulcers 📋 Executive Summary

The Sakita-Miwa classification is a globally recognized endoscopic grading system used to evaluate the life cycle and healing stages of peptic (specifically gastric) ulcers. Developed in Japan, it provides clinicians with a standardized framework to assess whether an ulcer is in an active, healing, or scarring phase. This classification directly informs treatment efficacy and determines the duration of acid-suppressive therapy. 🔬 Classification Breakdown

The system divides the progression of a gastric ulcer into three distinct stages, with each stage further sub-divided into two levels, creating a total of six sequential phases: 1. Active Stage (A)

A1 (Active 1): The ulcer is sharply demarcated with a deep crater. The floor is covered heavily with a thick, white or yellowish-gray exudate (slough). The surrounding mucosal margin is swollen and edematous.

A2 (Active 2): The edema in the surrounding mucosa begins to subside. The ulcer margin becomes clearer, and the depth may appear slightly shallower than in A1. 2. Healing Stage (H)

H1 (Healing 1): A thin white coat of exudate remains at the base, but regenerating epithelium (reddish in color) begins to appear at the margin. The ulcer size noticeably shrinks.

H2 (Healing 2): The ulcer becomes significantly smaller and shallower. The regenerative epithelium covers most of the ulcer base, leaving only a small amount of central white slough. 3. Scarring Stage (S)

S1 (Scarring 1 / Red Scar): The white exudate has completely disappeared. The ulcer is replaced by a flat, red, regenerating mucosal scar, often radiating outward in a star-like pattern.

S2 (Scarring 2 / White Scar): The redness fades over several months. The area turns into a pale, white, flat scar indistinguishable from normal mucosa except for its lack of normal gastric folds. 📊 Summary Table of Stages Core Endoscopic Appearance Active (A) A1

Deep crater, heavy white/gray slough, intense surrounding edema A2 Slough remains, but surrounding mucosal edema subsides Healing (H) H1

Ulcer shrinks; reddish regenerating epithelium appears at the borders H2

Ulcer is very small and shallow; regeneration dominates the floor Scarring (S) S1

Slough gone; replaced by a flat, red, radiating mucosal scar S2

Mature healing; the red scar fades to a stable, pale white scar 💡 Clinical Significance and Application

Treatment Monitoring: Gastroenterologists use the scale to measure how well an ulcer is responding to proton pump inhibitors (PPIs) or potassium-competitive acid blockers (P-CABs). Complete cure is typically defined when an ulcer successfully reaches the S1 or S2 stage.

Bleeding Risk: Ulcers identified in the A1 or A2 stages pose a much higher risk for acute upper gastrointestinal bleeding compared to those in the healing or scarring stages.

Therapeutic Endpoints: Many clinical trials for anti-ulcer medications use the transition from A-stage to S-stage within 4 to 8 weeks as their primary efficacy endpoint.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

The Sakita-Miwa classification is a standardized endoscopic grading system used primarily by gastroenterologists to assess the life cycle and healing stages of peptic ulcers (both gastric and duodenal). Developed by Japanese researchers Sakita and Miwa, it divides the progression of an ulcer into three main stages—Active (A), Healing (H), and Scarring (S)—each further subdivided into two substages.

This classification is a critical tool in clinical trials to evaluate the efficacy of acid-suppressing drugs like Proton Pump Inhibitors (PPIs) and Potassium-Competitive Acid Blockers (P-CABs). The Three Main Stages of the Sakita-Miwa System

The system tracks an ulcer from its most aggressive, open state to its final resolution as a healed scar. 1. Active Stage (A1 & A2)

In this stage, the ulcer is "active" and often associated with the highest risk of complications like bleeding.

A1 (Active 1): The ulcer is deep with a thick, white or yellowish-gray coating (slough) at the base. The margins are sharp and often swollen with edema.

A2 (Active 2): The edema at the ulcer margin begins to subside, and the ulcer base appears cleaner. The white coating may begin to thin. 2. Healing Stage (H1 & H2)

This transition indicates that medical treatment or natural recovery is effectively closing the wound.

H1 (Healing 1): The ulcer becomes shallower as granulation tissue fills the base. Regenerating epithelium (new skin) begins to creep in from the edges, often creating a "palisade" appearance of mucosal folds.

H2 (Healing 2): The ulcer is significantly smaller. The regenerating epithelium covers most of the base, leaving only a tiny central defect. 3. Scarring Stage (S1 & S2)

At this point, the ulcer is considered "endoscopically cured" because the mucosal defect has vanished.

S1 (Red Scar): The ulcer base is completely covered by new epithelium, but the area remains red and vascularized. This is a "fresh" scar.

S2 (White Scar): Over weeks or months, the redness fades into a white or pale scar as the tissue matures. This marks the final stage of healing. Clinical Utility and Scoring

In modern research, doctors often assign numerical scores to these stages to quantitatively measure improvement. For example, a study on ischemic colitis or Behçet’s disease might use the following scale: Clinical Meaning Numerical Score (Example) A1 Highly Active / Deep A2 Active / Slightly Improved H1 Early Healing H2 Advanced Healing S1 Red Scar (Healed) S2 White Scar (Mature) Why is this Classification Important?

The Sakita-Miwa classification (originally Sakita et al., 1971) is an endoscopic staging system used to categorize the lifecycle and healing progress of peptic ulcers. It is primarily used in East Asian clinical practice to assess gastric and duodenal ulcers.

The system divides ulcer progression into three main stages (Active, Healing, and Scarring), with each further subdivided into two sub-stages: 1. Active Stage (A) This stage represents the early, acute phase of the ulcer.

A1 (Active-1): The ulcer is at its peak activity. It is characterized by a thick white-plaque coating (slough), discrete margins, and significant surrounding edema.

A2 (Active-2): The edema begins to subside, and the ulcer margins become clearer. The mucus coating remains prominent. 2. Healing Stage (H) In this stage, signs of tissue repair become visible.

H1 (Healing-1): Regenerative epithelium (new skin-like tissue) begins to appear at the edges, making the ulcer shallower. The white coating starts to shrink.

H2 (Healing-2): The regenerative epithelium nearly covers the mucosal break. The ulcer is significantly smaller, and the coating is minimal. 3. Scarring Stage (S) This stage indicates complete or near-complete healing.

S1 (Scar-1 / Red Scar): The mucosal defect has closed. A red, flat scar is visible, representing new, highly vascularized tissue.

S2 (Scar-2 / White Scar): The final stage of healing. The redness disappears, leaving a white, flat scar as fibrous tissue matures and capillary density decreases. Summary Table Clinical Feature Highlights Active Thick white coating, edema, discrete margins Healing Epithelial regeneration, shallower base, shrinking coating Scarring Complete closure; initially red, maturing into a white scar

While the Forrest classification is typically used to assess bleeding risk, the Sakita-Miwa system is preferred for monitoring the quality and rate of healing over time.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Page 1 of 14 - GI Research

Understanding the Sakita-Miwa Classification for Peptic Ulcers

The Sakita-Miwa classification is a widely recognized endoscopic system used to evaluate the life cycle and healing progress of peptic ulcers, including gastric and duodenal ulcers. By categorizing ulcers into specific stages, clinicians can standardize the assessment of treatment efficacy, monitor healing quality, and predict the risk of complications like rebleeding. The Three Main Stages and Six Substages

The system divides the ulcer life cycle into three primary stages: Active (A), Healing (H), and Scarring (S). Each stage is further divided into two substages (1 and 2) to provide a granular view of the mucosal defect’s status. 1. Active Stage (A)

This stage represents the acute phase of the ulcer where the mucosal defect is most prominent.

A1 (Active-1): The ulcer is deep, and the base is covered with a thick white or yellowish slough (exudate). The surrounding mucosa is typically red and swollen (edematous).

A2 (Active-2): The edema in the surrounding mucosa begins to subside. The ulcer margin becomes sharper and more clearly defined, though the white coating remains thick. 2. Healing Stage (H)

As treatment progresses, the ulcer enters the healing phase, characterized by the gradual reduction of the slough and the appearance of regenerative tissue.

H1 (Healing-1): A thin white coating remains, but regenerating epithelium (new skin-like lining) begins to appear at the ulcer margins, often forming a "palisade" or star-like pattern as it creeps inward.

H2 (Healing-2): The ulcer becomes significantly shallower and smaller. The regenerative epithelium covers a larger portion of the base, and the white coating is markedly reduced. 3. Scarring Stage (S)

This final stage indicates that the ulcer has closed, though the underlying tissue is still maturing.

The Sakita-Miwa classification is a standardized medical staging system used primarily in East Asian clinical practice to evaluate the healing process of gastric and duodenal ulcers. It breaks down the "life cycle" of an ulcer into six distinct stages categorized under three main phases: Active, Healing, and Scarring. Active Phase (A)

This is the initial stage where the ulcer is fully formed and "open."

A1 (Active 1): The ulcer is at its peak. The surrounding mucosa (lining) is swollen and red, and the ulcer floor is covered with a thick "white coating" (slough).

A2 (Active 2): The swelling around the edges begins to subside, but the white coating remains thick and the ulcer crater is still very distinct. Healing Phase (H)

In this phase, the body begins to repair the damage and "fill in" the crater.

H1 (Healing 1): The ulcer crater is still visible, but the margins become sharper and the diameter of the defect shrinks to about half or two-thirds of the A1 stage. Regenerating epithelium (new skin) starts appearing at the edges.

H2 (Healing 2): The defect becomes much smaller. New regenerating epithelium covers most of the ulcer floor, though a small white coating may still be visible. Scarring Phase (S)

This is the final stage where the ulcer has effectively closed.

S1 (Scarring 1/Red Scar): The white coating has completely disappeared, and new epithelium fully covers the floor. Because the new tissue is thin and has many blood vessels, it appears as a "red scar".

S2 (Scarring 2/White Scar): Over several months to years, the redness fades. The scar becomes the same color as the surrounding tissue, often appearing as a "white scar".

💡 Clinical SignificanceDoctors use this system to determine if a treatment—like proton pump inhibitors (PPIs)—is working. An ulcer is medically considered "cured" once it reaches the S1 or S2 stage.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

However, "Sakitamiwa" is not a standard term in modern Western medical literature (ICD-10 or ICD-11). It is most likely a folk illness concept or a traditional classification of symptoms.

Below is a developed academic paper proposal structured to explore this topic. This paper treats "Sakitamiwa" as a Folk Illness Syndrome, analyzing it through the lenses of medical anthropology and ethnomedicine.

Title: Beyond the Biomedical: An Ethnomedical Analysis of 'Sakitamiwa' Classification and its Socio-Cultural Determinants

Abstract This paper investigates the classification of "Sakitamiwa," a term rooted in local indigenous medical systems, often referenced in Southeast Asian ethnomedicine. While modern biomedicine categorizes illness based on pathology and etiology, folk classifications like Sakitamiwa rely on symptom clusters, social context, and spiritual etiology. This study aims to deconstruct the Sakitamiwa classification, comparing its nosology with Western biomedical frameworks. By analyzing the symptomatic presentation and traditional healing rituals associated with Sakitamiwa, this paper argues that such classifications serve as crucial cultural coping mechanisms, offering a holistic framework that addresses the biological, psychological, and social well-being of the patient.